Supplementary Figure S6 from Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth

Katelyn L. Donahue; Hannah R. Watkoske; Padma Kadiyala; Wenting Du; Kristee Brown; Michael K. Scales; Ahmed M. Elhossiny; Carlos E. Espinoza; Emily L. Lasse Opsahl; Brian D. Griffith; Yukang Wen; Lei Sun; Ashley Velez-Delgado; Nur M. Renollet; Jacqueline Morales; Nicholas M. Nedzesky; Rachael K. Baliira; Rosa E. Menjivar; Paola I. Medina-Cabrera; Arvind Rao; Benjamin L. Allen; Jiaqi Shi; Timothy L. Frankel; Eileen S. Carpenter; Filip Bednar; Yaqing Zhang; Marina Pasca di Magliano

doi:10.1158/2159-8290.27168818

Abstract

Figure S6: Expression of fibroblast IL-33 is extrinsically induced by epithelial KrasG12D and requires JAK1/2-STAT3 activation throughout tumorigenesis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Donahue et al. (2024) studied this question.

synapsesocial.com/papers/68e55da7e2b3180350efad88 https://doi.org/10.1158/2159-8290.27168818

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure S6 from Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth

Abstract

Discussion

Cite This Study

Supplementary Figure S6 from Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth

Abstract

Discussion

Cite This Study

Keep reading

More related papers

Keep reading

More related papers